Invention Grant
US09408793B2 Selective compounds inhibiting CYP26A1 useful in cosmetic and pharmaceutical compositions
有权
抑制CYP26A1的选择性化合物可用于化妆品和药物组合物
- Patent Title: Selective compounds inhibiting CYP26A1 useful in cosmetic and pharmaceutical compositions
- Patent Title (中): 抑制CYP26A1的选择性化合物可用于化妆品和药物组合物
-
Application No.: US14417035Application Date: 2013-07-23
-
Publication No.: US09408793B2Publication Date: 2016-08-09
- Inventor: Jean-Guy Boiteau , Michel Rivier , Gérard Feraille , André Jomard
- Applicant: GALDERMA RESEARCH & DEVELOPMENT
- Applicant Address: FR Biot
- Assignee: GALDERMA RESEARCH & DEVELOPMENT
- Current Assignee: GALDERMA RESEARCH & DEVELOPMENT
- Current Assignee Address: FR Biot
- Agency: Dentons US LLP
- Priority: FR1257128 20120723
- International Application: PCT/FR2013/051769 WO 20130723
- International Announcement: WO2014/016507 WO 20140130
- Main IPC: A61K8/46
- IPC: A61K8/46 ; A61Q19/08 ; C07C317/44 ; A61Q19/02 ; A61Q19/04 ; A61Q19/00
Abstract:
Compounds or salts thereof are described that correspond to general formula (I) below: Also described, are pharmaceutical and cosmetic compositions that include these compounds. Methods of using these compounds and compositions for the treatment of pathological conditions are also described.
Public/Granted literature
- US20150190323A1 SELECTIVE COMPOUNDS INHIBITING CYP26A1 USEFUL IN COSMETIC AND PHARMACEUTICAL COMPOSITIONS Public/Granted day:2015-07-09
Information query
